Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acer MedicalROCO:6857 -0.22%52 PS Ratio is 23.45 as of Jul. 26, 2026, which is 66% below its 10-year median of 68.65. GuruFocus rates ROCO:6857 with a GF Score™ of 52/100 and a GF Value™ of NT$264.59 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 658 Healthcare Providers & Services companies, Acer Medical ranks worse than 96.05% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Acer Medical's share price is NT$92.50.
Acer Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.94. Hence, Acer Medical's PS Ratio for today is 23.45.
Good Sign:
Acer Medical Inc stock PS Ratio (=23.45) is close to 5-year low of 23.33.
The historical rank and industry rank for Acer Medical's PS Ratio or its related term are showing as below:
ROCO:6857'
s PS Ratio Range Over the Past 10 Years
Min: 23.33 Med: 68.65 Max: 229.46
Current: 23.45
During the past 7 years, Acer Medical's highest PS Ratio was 229.46. The lowest was 23.33. And the median was 68.65.
ROCO:6857's PS Ratio is ranked worse than 96.05% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 1.465
vs ROCO:6857: 23.45
Acer Medical Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Acer Medical was 19.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 55.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 69.60% per year.
During the past 7 years, Acer Medical's highest 3-Year average Revenue per Share Growth Rate was 304.50% per year. The lowest was 38.40% per year. And the median was 82.45% per year.
Back to Basics: PS Ratio
Acer Medical (ROCO:6857) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Acer Medical PS Ratio Related Terms
Acer Medical PS Ratio Historical Data
* Premium members only.
The historical data trend for Acer Medical's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Acer Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's PS Ratio distribution charts can be found below:
* The bar in red indicates where Acer Medical's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Acer Medical's PS Ratio for today is calculated as
Acer Medical's Share Price of today is NT$92.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acer Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.94.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Acer Medical (ROCO:6857) has a PS Ratio of 23.45 as of Jul. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Acer Medical and its competitors. This is 66% below median its historical median of 68.65. Over the past decade, Acer Medical's PS Ratio has ranged from 23.33 to 229.46. According to the industry distribution chart, Acer Medical ranks #632 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 96%.
Is Acer Medical's PS Ratio too high?
Acer Medical's current PS Ratio of 23.45 is 66% below median its 10-year median of 68.65. Over the past 10 years, this metric has ranged from a low of 23.33 to a high of 229.46. The Healthcare Providers & Services industry median PS Ratio is 1.47. Acer Medical's value of 23.45 is 1500.7% above this industry median. Based on the distribution chart, Acer Medical ranks #632 out of 658 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Acer Medical has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #632 out of 658 companies for PS Ratio. This places Acer Medical in the lower half of its industry. The industry median PS Ratio is 1.47. Acer Medical's value of 23.45 is 1500.7% above this benchmark. Historically, Acer Medical's own PS Ratio has ranged from 23.33 to 229.46 over the past decade. While the company's 10-year median is 68.65 vs. the industry median of 1.47, Acer Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acer Medical's current PS Ratio of 23.45 is 1500.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Acer Medical and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current PS Ratio is 23.45, which is 66% below median its own 10-year median of 68.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$264.59, compared to a current price of NT$92.50 — trading 65% below its estimated fair value. The current PS Ratio is 23.45, which is 66% below median its 10-year median of 68.65 and 1500.7% above the Healthcare Providers & Services industry median of 1.47. Acer Medical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current PS Ratio is 23.45 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$92.50 is trading 65% below its estimated GF Value™ of NT$264.59.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
PS Ratio: 23.45 (66% below median its 10-year median of 68.65)
GF Value™: NT$264.59 vs. price of NT$92.50 (65% below fair value)
Industry Position: 1500.7% above the Healthcare Providers & Services median (#632 of 658)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
52GF Score
Get the complete analysis for ROCO:6857
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
